Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$586.90 USD

586.90
541,803

+0.79 (0.13%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $586.68 -0.22 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (176 out of 248)

Industry: Medical - Dental Supplies

Better trading starts here.

Brokerage Reports

Research for MCK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

McKesson Corporation [MCK]

Reports for Purchase

Showing records 341 - 360 ( 360 total )

Company: McKesson Corporation

Industry: Medical Services

Record: 341

02/22/2011

Company Report

Pages: 8

Price: 24.95

Company: McKesson Corporation

Industry: Medical Services

Record: 342

02/01/2011

Company Report

Pages: 5

EPS Beat & Guidance Raise: Raising Target to $87

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 343

01/12/2011

Company Report

Pages: 6

Raising Estimates on USON Acquisition: Increasing Price Target to $86.

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 25.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 344

01/04/2011

Industry Report

Pages: 4

2011 Outlook: All Systems GO?

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 345

12/10/2010

Industry Report

Pages: 4

Healthcare IT & Services - ASHP Wrap: "Closing the Loop"

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 346

11/24/2010

Company Report

Pages: 8

Price: 24.95

Company: McKesson Corporation

Industry: Medical Services

Record: 347

11/02/2010

Company Report

Pages: 5

US Oncology Purchase Should Lift Earnings - Reiterate BUY

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 348

10/27/2010

Company Report

Pages: 6

No Messin'' with McKesson: Reiterate Buy and $75 Target

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 25.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 349

10/22/2010

Company Report

Pages: 5

Q2 Preview

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 350

09/01/2010

Industry Report

Pages: 4

Ten-Hut! Military Health System to Replace Aging EMR System

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 351

08/30/2010

Company Report

Pages: 7

Price: 24.95

Company: McKesson Corporation

Industry: Medical Services

Record: 352

08/02/2010

Company Report

Pages: 6

Solid Q1: Reiterate BUY, While Reducing Price Target to $75.

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 25.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 353

07/28/2010

Company Report

Pages: 5

Q1 Preview: Looking Good, Despite Multiple Compression.

Provider: AURIGA USA

Analyst: MANNHEIMER G

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 354

06/18/2010

Company Report

Pages: 8

Price: 24.95

Company: McKesson Corporation

Industry: Medical Services

Record: 355

05/19/2010

Company Report

Pages: 7

Billion-Dollar Buyback Suggests Healthcare IT Valuations are Excessive.

Provider: AURIGA USA

Price: 25.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 356

05/04/2010

Company Report

Pages: 6

There''s No "Messin" With McKesson; Raising Price Target to $78

Provider: AURIGA USA

Price: 25.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 357

04/29/2010

Company Report

Pages: 5

Q4 Earnings Preview: FY11 Guidance to Dictate Stock''s Direction .

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 358

03/26/2010

Industry Report

Pages: 3

Health IT Win-Loss Analysis: Epic Systems on Top

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party

Company: McKesson Corporation

Industry: Medical Services

Record: 359

03/11/2010

Company Report

Pages: 7

Price: 24.95

Company: McKesson Corporation

Industry: Medical Services

Record: 360

03/03/2010

Industry Report

Pages: 5

HIMSS Takeaways - Sense of Urgency to Adopt IT is Building

Provider: AURIGA USA

Price: 10.00

Research Provided by a Third Party